Cytogen Inc Total Liabilities

Latest as of December 2025: ₩26.25 Billion KRW ≈ $17.79 Million USD

Cytogen Inc total liabilities. Based on the latest financial reports, Cytogen Inc (217330) has total liabilities worth ₩26.25 Billion KRW (≈ $17.79 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 217330 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Cytogen Inc (2014–2025)

Total liabilities of Cytogen Inc from 2014 to 2025. This chart illustrates how Cytogen Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Cytogen Inc (217330) long-term investment share to see how much of total assets are deployed in long-term investments.

Cytogen Inc Competitors by Total Liabilities

The table below lists competitors of Cytogen Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Lottery.com, Inc. Common Stock NASDAQ:LTRY	USA	$30.40 Million
Corem Property Group AB (publ) ST:CORE-A	Sweden	Skr38.77 Billion
Angus Ventures Inc V:GUS	Canada	CA$1.77 Million
INFOMARK Co. Ltd KQ:175140	Korea	₩18.78 Billion
Mtag Group Berhad KLSE:0213	Malaysia	RM10.99 Million
Hiroca Holdings Ltd TW:1338	Taiwan	NT$7.68 Billion
Westport Fuel Systems Inc TO:WPRT	Canada	CA$22.19 Million
Salter Brothers Emerging Companies Ltd AU:SB2	Australia	AU$1.98 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Cytogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Cytogen Inc asset portfolio.

Liquidity & Leverage Metrics

Cytogen Inc Total Liabilities Ratios Explained

Cytogen Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.74	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cytogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cytogen Inc (2014–2025)

The table below shows the annual total liabilities of Cytogen Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩26.25 Billion ≈ $17.79 Million	+9.85%
2024-12-31	₩23.89 Billion ≈ $16.19 Million	+13.27%
2023-12-31	₩21.09 Billion ≈ $14.30 Million	-40.69%
2022-12-31	₩35.56 Billion ≈ $24.10 Million	+9.36%
2021-12-31	₩32.52 Billion ≈ $22.04 Million	+226.05%
2020-12-31	₩9.97 Billion ≈ $6.76 Million	+455.30%
2019-12-31	₩1.80 Billion ≈ $1.22 Million	+152.43%
2018-12-31	₩711.51 Million ≈ $482.18K	-24.91%
2017-12-31	₩947.50 Million ≈ $642.11K	-79.34%
2016-12-31	₩4.59 Billion ≈ $3.11 Million	+187.30%
2015-12-31	₩1.60 Billion ≈ $1.08 Million	+1.68%
2014-12-31	₩1.57 Billion ≈ $1.06 Million	--

About Cytogen Inc

KQ:217330 Korea Diagnostics & Research

Market Cap

$34.86 Million

₩51.45 Billion KRW

Market Cap Rank

#23025 Global

#1551 in Korea

Share Price

₩2230.00

Change (1 day)

+0.22%

52-Week Range

₩2225.00 - ₩9420.00

All Time High

₩22599.98